Clonal Hematopoiesis Induces Premature Stromal Senescence in Bone Marrow

Researchers at The Jackson Laboratory mapped single-cell gene expression in bone marrow from Tet2- and Dnmt3a-mutant mice and age-matched human samples. Mutant hematopoietic cells triggered p16INK4a and SASP upregulation in adjacent stromal cells; these senescent stromal cells then secreted factors that selectively supported mutant stem-cell self-renewal while impairing normal hematopoiesis. Pharmacologic or genetic clearance of p16-positive stromal cells reduced clone size by 40-60% and delayed leukemic transformation in serial transplantation assays.

The findings invert the prevailing model that fitness-conferring mutations act cell-autonomously; instead, clones remodel their niche to amplify selective advantage. This mechanism also explains the excess cardiovascular risk observed in clonal hematopoiesis cohorts, because senescent stromal cells release pro-inflammatory cytokines that promote atherosclerosis.

Related work in Nature (2024) on senescent niches in myelodysplastic syndromes and in Cell Stem Cell (2023) on niche remodeling by JAK2-mutant clones supports a convergent pathway. The next required study is a prospective trial of senolytics in individuals with high-risk clonal hematopoiesis (VAF >10%) to test whether niche normalization lowers progression to overt malignancy within 3 years.